HIV Child Medicine That Cut the ‘Yuck’ Cleared in South Africa
- World’s worst affected nation likely to see greater compliance
- More work needed to eliminate mother-to-child transmission
This article is for subscribers only.
South Africa’s approval of two HIV therapies for children is likely to improve treatment compliance in the world’s worst affected nation as the new products are more palatable for infants than previous incarnations.
Babies and toddlers are prone to spit out medications they don’t like and the newly approved treatments take away the “yuck” factor, Linda-Gail Bekker, director of the Desmond Tutu HIV Center, said Tuesday.